Global Prostate Biopsy Market 2017-2021


#1027782

97pages

Technavio

$ 3500

In Stock

About Prostate Biopsy Market
Biopsy is a clinical procedure primarily used in the detection and extraction of malignant or cancerous cells and their abnormal growth in the body for further analysis and interpretation of diseases. The purpose of removing tissues or cells during the procedure is mainly to limit the spread of tumor, minimize morbidity, and eliminate interference with future treatments.

Technavios analysts forecast the global prostate biopsy market to grow at a CAGR of 12.66% during the period 2017-2021.

Covered in this report
The report covers the present scenario and the growth prospects of the global prostate biopsy market for 2017-2021. To calculate the market size, the report considers the new sales of devices and products used in prostate biopsy

The market is divided into the following segments based on geography:
Americas
EMEA
APAC

Technavio's report, Global Prostate Biopsy Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
C.R. Bard
Cook Medical
Endomed Systems
SOMATEX Medical Technologies
Biomedical

Other prominent vendors
Amecath
AprioMed
Argon Medical Devices
Biopsybell
Boston Scientific
Exosome Diagnostics
MDNA Life Sciences
MDxHealth
Mller Medical
Pathway Genomics
Predicine
Sterylab
TSK Laboratory Europe
UroMed
Urotech

Market driver
Growing incidences of prostate cancer
For a full, detailed list, view our report

Market challenge
Complications associated with prostate needle biopsies
For a full, detailed list, view our report

Market trend
New product launches and R&D activities
For a full, detailed list, view our report

Key questions answered in this report
What will the market size be in 2021 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analysts time when you purchase this market report. Details are provided within the report.


Table of Contents

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction


Key market highlights
Prostate cancer: An overview


PART 05: Market landscape


Market overview
Market size and forecast
Five forces analysis


PART 06: Market segmentation by product


Market overview
Global prostate needle biopsy market
Global prostate liquid biopsy market


PART 07: Market segmentation by end-user


Hospitals
ASCs
Diagnostic centers
Key buying criteria


PART 08: Geographical segmentation


Prostate biopsy market in Americas
Prostate biopsy market in EMEA
Prostate biopsy market in APAC


PART 09: Market drivers


Growing incidences of prostate cancer
Recurrent revenue from repeat biopsy tests
Growing number of diagnostic centers


PART 10: Impact of drivers

PART 11: Market challenges


Complications associated with prostate needle biopsies
High cost of biopsy procedure
Inaccurate test results
Limited technical skills


PART 12: Impact of drivers and challenges

PART 13: Market trends


New product launches and R&D activities
Growing demand for MRI and Ultrasound guided prostate biopsy procedures
High growth potential of prostate liquid biopsy tests
Growing focus toward combination of traditional and liquid biopsy tests


PART 14: Vendor landscape


Competitive scenario


PART 15: Key vendor analysis


C.R. Bard
Cook Medical
Endomed Systems
SOMATEX Medical Technologies
Biomedical
Other prominent vendors


PART 16: Appendix


List of abbreviations


PART 17: Explore Technavio
List of Exhibits

Exhibit 01: Incidence rate of prostate cancer in different age groups 2015

Exhibit 02: Stages of prostate cancer and various diagnostics tools used for detection

Exhibit 03: Snapshot of global prostate biopsy market

Exhibit 04: Global prostate biopsy market 2016-2021 ($ millions)

Exhibit 05: Prostate cancer: Key statistics

Exhibit 06: Global prostate biopsy market analysis: Developed and emerging markets

Exhibit 07: Five forces analysis

Exhibit 08: Segmentation of global prostate biopsy market by product type

Exhibit 09: Two most common biopsies for prostate cancer

Exhibit 10: Share of each product type in the global prostate biopsy market 2016 and 2021 (%)

Exhibit 11: Global prostate biopsy market by product analysis 2016

Exhibit 12: Global prostate biopsy market: Lifecycle analysis 2016

Exhibit 13: Segmentation of global prostate biopsy market by product 2016-2021 ($ millions)

Exhibit 14: Segmentation of global prostate biopsy market by product 2016-2021 (%)

Exhibit 15: Global prostate needle biopsy market 2016-2021 ($ millions)

Exhibit 16: Types of prostate biopsy devices

Exhibit 17: Types of prostate biopsy guns

Exhibit 18: Percentage share of reusable and disposable prostate biopsy guns 2016

Exhibit 19: Benefits of advanced biopsy needles

Exhibit 20: Global prostate needle biopsy market segmentation percentage split 2016

Exhibit 21: Global prostate liquid biopsy market 2016-2021 ($ millions)

Exhibit 22: Global prostate biopsy market by end-user 2016 (%)

Exhibit 23: Factors affecting the purchase decision of prostate biopsy devices

Exhibit 24: Global prostate biopsy market segmentation by geography 2016-2021 (%)

Exhibit 25: Global prostate biopsy market analysis by geography 2016

Exhibit 26: Global prostate biopsy market: Geography market growth lifecycle analysis 2016

Exhibit 27: Country wise presence of global prostate biopsy market

Exhibit 28: Geographical overview of global prostate biopsy market 2016-2021

Exhibit 29: Prostate biopsy market in Americas 2016-2021 ($ millions)

Exhibit 30: Prostate biopsy market in EMEA 2016-2021 ($ millions)

Exhibit 31: Prostate biopsy market in APAC 2016-2021 ($ millions)

Exhibit 32: Global prostate biopsy market by geography 2016-2021 ($ millions)

Exhibit 33: Global prostate biopsy market by geography 2016-2021 (%)

Exhibit 34: Impact of drivers

Exhibit 35: Cost of biopsies for uninsured people in US, 2015

Exhibit 36: Impact of drivers and challenges

Exhibit 37: Competitive structure analysis of global prostate biopsy market 2016

Exhibit 38: Competitive parameters in global prostate biopsy market

Exhibit 39: C.R. Bard strength assessment

Exhibit 40: C.R. Bard strategy assessment

Exhibit 41: C.R. Bard opportunity assessment

Exhibit 42: Key highlights of Cook Medical

Exhibit 43: Cook Medical strength assessment

Exhibit 44: Cook Medical strategy assessment

Exhibit 45: Cook Medical opportunity assessment

Exhibit 46: Endomed Systems strength assessment

Exhibit 47: Endomed Systems strategy assessment

Exhibit 48: Endomed Systems opportunity assessment

Exhibit 49: Key highlights of SOMATEX Medical Technologies

Exhibit 50: SOMATEX Medical Technologies strength assessment

Exhibit 51: SOMATEX Medical Technologies strategy assessment

Exhibit 52: SOMATEX Medical Technologies opportunity assessment

Exhibit 53: Key highlights of Biomedical

Exhibit 54: Biomedical strength assessment

Exhibit 55: Biomedical strategy assessment

Exhibit 56: Biomedical opportunity assessment